Jinmei Zhou
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Single-cell profiling reveals distinct populations of tumor-associated macrophages and metastatic tumor cells in breast cancer brain metastasis.
Journal: Cell death & disease
Published: October 24, 2025
Development of a prognostic risk stratification model for HER2-positive breast cancer brain metastasis and its implications in guiding treatment decisions.
Journal: Scientific reports
Published: March 17, 2025
Efficacy and safety of trastuzumab deruxtecan in HER2-positive breast cancer patients with brain metastases after failure of pyrotinib-based therapy.
Journal: Scientific reports
Published: January 30, 2025
Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy.
Journal: Breast cancer research and treatment
Published: April 03, 2023
Efficacy and safety of pyrotinib and radiotherapy vs. pyrotinib-based therapy in patients with HER2+ breast cancer with brain metastasis: a retrospective cohort study.
Journal: Annals of translational medicine
Published: September 19, 2022
Clinical outcomes of tucidinostat-based therapy after prior CDK4/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: September 13, 2022
An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer.
Journal: Frontiers in oncology
Published: June 11, 2022
Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy.
Journal: Frontiers in oncology
Published: January 31, 2022
Meaningful interpretation of serum HER2 ECD levels requires clear patient clinical background, and serves several functions in the efficient management of breast cancer patients.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: March 08, 2016
Clinical efficacy and safety of trastuzumab plus capecitabine as first-line therapy for HER-2 positive metastatic breast cancer
Journal: Zhonghua yi xue za zhi
Published: December 30, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026